MoonLake Immunotherapeutics (MLTX)

• Market cap: $1.15B
• 1 day: -0.25%
• 5 days: -2.99%
• 1 month: 18.32%
• 3 months: 65.07%
• 6 months: -70.24%
• Year to date: 35.65%
• 1 year: -64.07%
• 5 years: 46.17%
• 10 years: 54.53%
• Sector: Healthcare
• Industry: Biotechnology

About: MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Employees: 100